Antineoplastic Combined Chemotherapy ProtocolsBlack or African AmericanC-Reactive Protein
Dr. Pramvir Singh Verma, MD
NPI1609854660
- Publications
- 1
- Clinical trials
- 7
- Hospital affiliations
- 1
- Industry payments
- $7,210
- State license
- 1
- Practice address
- 9300 Dewitt Loop, Fort Belvoir, VA 22060
- Practice phone
- Call (571) 231-3224
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Verma's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Pramvir Singh Verma is a hematologist and oncologist in Fort Belvoir, Virginia
Dr. Verma practices at Alexander T. Augusta Military Medical Center in Fort Belvoir, Virginia, part of United States Department of War.
Dr. Verma's NPI, 1609854660, was assigned on January 9, 2006. Dr. Verma holds Indiana license 01055327A.
NPI and contact details
- NPI
- 1609854660NPI Registry (opens in a new tab)
- NPI enumeration date
- January 9, 2006
- NPI status
- Active
- Practice phone
- (571) 231-3224
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Pramvir Singh Verma practices at Alexander T. Augusta Military Medical Center in Fort Belvoir, Virginia
Dr. Verma's primary practice is Alexander T. Augusta Military Medical Center, at 9300 Dewitt Loop, Fort Belvoir, VA 22060 in Fairfax County. The practice phone is (571) 231-3224.
- Alexander T. Augusta Military Medical Center9300 Dewitt Loop, Fort Belvoir, VA 22060 · Fairfax CountyPhone(571) 231-3224
Source: Dmand AI Affiliation Data
Dr. Pramvir Singh Verma is affiliated with 1 site of care
Dr. Verma's primary practice is Alexander T. Augusta Military Medical Center in Fort Belvoir, Virginia, part of United States Department of War. Dr. Verma's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Pramvir Singh Verma's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verma practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Alexander T. Augusta Military Medical Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Verma practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across United States Department of War and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Pramvir Singh Verma is one of 297 hematologists and oncologists in Virginia
Hematology and oncology is Dr. Verma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Verma is licensed in Indiana.
Specialties and state licenses
- Hematology and oncology, IndianaPrimary
Hematologists and oncologists near Dr. Verma
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
297hematologists and oncologists in Virginia
7hematologists and oncologists in Fort Belvoir
3hematologists and oncologists at Alexander T. Augusta Military Medical CenterSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Pramvir Singh Verma's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Verma's median patient age at 68, with 68% women.
Dr. Verma's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women68%
- Men32%
Source: Dmand AI Patient Panel Data
Dr. Pramvir Singh Verma has 1 publication on record
Dmand AI links 1 paper to Dr. Verma.
Papers1
Recent publications by Dr. Verma
See who Dr. Verma researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Verma works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Pramvir Singh Verma has worked on 7 clinical trials
Dmand AI links Dr. Verma to 7 clinical trials, 4 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Neoplasm Metastasis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Verma that name 2 trials.
Clinical trials with Dr. Verma by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Verma's trials
- Breast Neoplasms
- Breast Diseases
- Neoplasm Metastasis
- Neoplastic Processes
- Oral Ulcer
Investigators on the most trials with Dr. Verma
- Shakeela Wazeen Bahadur, MD3 shared trials
- Manuel Borrego, MD3 shared trials
- Jennifer F. Carney, MD3 shared trials
Recent clinical trials with Dr. Verma
Breast NeoplasmsBreast DiseasesElacestrantStandard of Care
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients (opens in a new tab)
CompletedPhase 3
Oral UlcerStomatitisGC4419 90mg
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC (opens in a new tab)
TerminatedPhase 2
Small Cell Lung CarcinomaCarcinoma, BronchogenicAtezolizumabCarboplatinEtoposide
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer (opens in a new tab)
CompletedPhase 3
Neoplasm MetastasisNeoplastic ProcessesMargetuximabTrastuzumabPhysician's choice of chemotherapy.
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (opens in a new tab)
CompletedPhase 3
Neoplasm MetastasisNeoplastic ProcessesDCVAC/PCa
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Pramvir Singh Verma received $7,210 in industry payments from 2016 to 2025
CMS Open Payments shows 231 general payments to Dr. Verma from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,297. It also lists 2 research payments totaling $2,135 from 2021 to 2023, naming 2 clinical trials.
General payments to Dr. Verma by program year, 2016 to 2025
General payments to Dr. Verma by kind, 2016 to 2025
$7.2Kin total
- Food and beverage$3,94055%
- Consulting fees$3,16544%
- Speaker and faculty fees$1051%
Companies that paid Dr. Verma the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Pramvir Singh Verma's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Pramvir Singh Verma
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Pramvir Singh Verma's NPI number?
Dr. Pramvir Singh Verma's NPI number is 1609854660. It was assigned on January 9, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Pramvir Singh Verma?
Dr. Pramvir Singh Verma is a hematologist and oncologist in Fort Belvoir, Virginia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Pramvir Singh Verma practice?
Dr. Verma practices at 9300 Dewitt Loop, Fort Belvoir, VA 22060. Dr. Verma's primary practice is Alexander T. Augusta Military Medical Center in Fort Belvoir, Virginia, part of United States Department of War.
What is Dr. Pramvir Singh Verma's office phone number?
The practice phone on file for Dr. Verma is (571) 231-3224.
What is Dr. Pramvir Singh Verma's medical license number?
Dr. Verma holds Indiana license 01055327A.
Which hospitals is Dr. Pramvir Singh Verma affiliated with?
Dr. Verma practices at Alexander T. Augusta Military Medical Center in Fort Belvoir, Virginia.
Has Dr. Pramvir Singh Verma received payments from drug or device companies?
CMS Open Payments shows $7,210 in general payments to Dr. Verma from 35 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Pramvir Singh Verma been practicing?
Dr. Verma's NPI was assigned in 2006.
Does Dr. Pramvir Singh Verma do research?
Dmand AI links 1 publication to Dr. Verma. Dr. Verma has worked on 7 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card